Nuvalent to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Rhea-AI Summary

Nuvalent, Inc. (NUVL) is set to participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference. The chat will feature the CEO and CFO and will be available via live webcast on the company's website. The event aims to discuss the company's focus on creating targeted therapies for cancer treatment.

CAMBRIDGE, Mass., Feb. 1, 2024 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in a fireside chat during the Guggenheim Healthcare Talks 6^th Annual Biotechnology Conference on Thursday, February 8, 2024, at 10:30 a.m. ET in NYC.

A live webcast will be available in the Investors section of the company's website at www.nuvalent.com, and archived for 30 days following the presentation.

About Nuvalent

Nuvalent, Inc. (Nasdaq: NUVL) is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in chemistry and structure-based drug design, we develop innovative small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases, and drive more durable responses. Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-positive non-small cell lung cancer, and multiple discovery-stage research programs.

View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvalent-to-participate-in-the-guggenheim-healthcare-talks-6th-annual-biotechnology-conference-302050153.html

SOURCE Nuvalent, Inc.

FAQ

When is Nuvalent, Inc. participating in the fireside chat?

Nuvalent, Inc. is participating in the fireside chat during the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Thursday, February 8, 2024, at 10:30 a.m. ET in NYC.

Who will be participating in the fireside chat?

The CEO, James Porter, Ph.D., and the CFO, Alexandra Balcom, will be participating in the fireside chat.

Where can the live webcast of the fireside chat be accessed?

The live webcast will be available in the Investors section of Nuvalent, Inc.'s website at www.nuvalent.com.

How long will the webcast be available for viewing after the presentation?

The webcast will be archived for 30 days following the presentation.